All participants had significant improvements in all primary outcome measures. Mean weight reduction in the chitosan groups ranged from 7.19 to 8.17 kg, while total cholesterol reduction ranged from 23.3% to 25.3%. All therapies were well tolerated; the most common adverse effect was mild and transient nausea.